Share your videos with the world

Politicians, economists, media and researchers from around the world will gather in Tunis from May 14 to 17 to take part in the Global Forum on Modern Direct Democracy. As the forum's media partner, SWI swissinfo.ch will report live from the event, and officially launch its microsite dedicated to direct democracy and its partner site, people2power.info. The aim of the microsite swissinfo.ch/directdemocracy - online in 10 languages since December 2014 - is to inform readers about political rights and democratic processes so they can form their own opinions in order to play a greater role in the decision-making process. Switzerland's unique form of participative democracy is the focus of the site whereas people2power.info offers a global view. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523351-swissinfo-direct-democracy-tunis/

Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments. To view the multimedia release go to: https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/

The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine. Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members. To view the multimedia release go to: http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/